Drug
Vorinostat
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | Febrile Neutropenia | 239 | 35.4 | 39.7 | signal |
| 2 | Lymphopenia | 42 | 29.3 | 29.8 | signal |
| 3 | Acute Myeloid Leukaemia | 40 | 25.2 | 25.6 | signal |
| 4 | Electrocardiogram Qt Prolonged | 68 | 18.5 | 19.1 | signal |
| 5 | Haematotoxicity | 17 | 17.9 | 18.1 | signal |
| 6 | Lung Infection | 28 | 17.4 | 17.6 | signal |
| 7 | Mucosal Inflammation | 39 | 14.6 | 14.9 | signal |
| 8 | Device Related Infection | 22 | 13.9 | 14.1 | signal |
| 9 | Myelodysplastic Syndrome | 20 | 13.5 | 13.6 | signal |
| 10 | Hyperbilirubinaemia | 14 | 13.3 | 13.4 | signal |
| 11 | Thrombocytopenia | 151 | 13.2 | 14.2 | signal |
| 12 | Hypocalcaemia | 25 | 13.0 | 13.1 | signal |
| 13 | Neutrophil Count Decreased | 52 | 12.6 | 12.8 | signal |
| 14 | Hypokalaemia | 52 | 11.1 | 11.3 | signal |
| 15 | Bacteraemia | 13 | 10.8 | 10.9 | signal |
| 16 | Haemorrhage Intracranial | 16 | 10.4 | 10.5 | signal |
| 17 | Sinus Bradycardia | 10 | 10.1 | 10.1 | signal |
| 18 | Platelet Count Decreased | 106 | 9.7 | 10.2 | signal |
| 19 | Sepsis | 111 | 9.7 | 10.2 | signal |
| 20 | Small Intestinal Obstruction | 12 | 9.6 | 9.6 | signal |
| 21 | Bone Marrow Failure | 20 | 9.6 | 9.6 | signal |
| 22 | Hyperglycaemia | 35 | 9.4 | 9.6 | signal |
| 23 | Pneumonitis | 26 | 9.4 | 9.5 | signal |
| 24 | Lymphocyte Count Decreased | 17 | 9.4 | 9.5 | signal |
| 25 | Hypercalcaemia | 11 | 8.7 | 8.8 | signal |
| 26 | Hypoxia | 31 | 8.6 | 8.8 | signal |
| 27 | Candida Infection | 14 | 8.2 | 8.3 | signal |
| 28 | Electrolyte Imbalance | 9 | 7.6 | 7.7 | signal |
| 29 | Dehydration | 102 | 7.5 | 7.8 | signal |
| 30 | Hyponatraemia | 42 | 7.3 | 7.4 | signal |
| 31 | Colitis | 28 | 7.3 | 7.4 | signal |
| 32 | Choking | 14 | 7.0 | 7.1 | signal |
| 33 | Respiratory Failure | 52 | 7.0 | 7.1 | signal |
| 34 | Anaemia | 135 | 6.9 | 7.3 | signal |
| 35 | Sinus Tachycardia | 10 | 6.9 | 6.9 | signal |
| 36 | Gastric Haemorrhage | 8 | 6.8 | 6.8 | signal |
| 37 | Anorexia | 9 | 6.7 | 6.8 | signal |
| 38 | Neutropenia | 93 | 6.7 | 7.0 | signal |
| 39 | Brain Neoplasm | 6 | 6.4 | 6.4 | signal |
| 40 | Metastases To Lung | 7 | 5.9 | 5.9 | signal |
| 41 | Respiratory Arrest | 16 | 5.6 | 5.7 | signal |
| 42 | Sudden Death | 6 | 5.5 | 5.5 | signal |
| 43 | Renal Failure Acute | 24 | 5.5 | 5.5 | signal |
| 44 | Appendicitis | 5 | 5.3 | 5.3 | signal |
| 45 | Product Use In Unapproved Indication | 130 | 5.2 | 5.5 | signal |
| 46 | Posterior Reversible Encephalopathy Syndrome | 5 | 5.1 | 5.1 | signal |
| 47 | Pericardial Effusion | 12 | 5.1 | 5.1 | signal |
| 48 | Malignant Neoplasm Progression | 53 | 5.1 | 5.2 | signal |
| 49 | Disease Progression | 61 | 5.1 | 5.2 | signal |
| 50 | Multi-organ Failure | 9 | 5.0 | 5.0 | signal |
| 51 | Plasma Cell Myeloma | 18 | 4.5 | 4.5 | signal |
| 52 | Pancytopenia | 25 | 4.4 | 4.4 | signal |
| 53 | Intestinal Perforation | 5 | 4.3 | 4.4 | signal |
| 54 | Epistaxis | 33 | 4.3 | 4.4 | signal |
| 55 | White Blood Cell Count Decreased | 46 | 4.1 | 4.2 | signal |
| 56 | Cytopenia | 5 | 4.1 | 4.1 | signal |
| 57 | Hepatitis C | 5 | 4.0 | 4.0 | signal |
| 58 | Metastases To Central Nervous System | 5 | 3.8 | 3.8 | signal |
| 59 | Nephropathy Toxic | 4 | 3.5 | 3.5 | signal |
| 60 | Convulsion | 17 | 2.9 | 2.9 | signal |
| 61 | Palmar-plantar Erythrodysaesthesia Syndrome | 5 | 2.1 | 2.1 | no signal |
| 62 | Intentional Drug Misuse | 4 | 1.8 | 1.8 | no signal |
| 63 | Myelosuppression | 5 | 1.4 | 1.4 | no signal |